GlassScriptPhysician profile
Jennifer M Smith
NPI 1154778181
$2,318.06
in general payments reported to CMS, 2019-2025
19 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.42 · 2020: $286 · 2021: $285 · 2022: $550 · 2023: $491 · 2024: $425 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,164.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $417.74 | 2020-2023 | |
| Inari Medical, INC. | $347.10 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Gilead Sciences, INC. | $241.22 | 2022-2025 | Veklury |
| E.R. Squibb & Sons, L.L.C. | $241.06 | 2020-2025 | Eliquis |
| Alexion Pharmaceuticals, INC. | $224.83 | 2022-2023 | Ultomiris, Soliris |
| Janssen Pharmaceuticals, INC | $170.95 | 2020-2023 | Xarelto |
| Abbvie INC. | $160.72 | 2025 | |
| Novartis Pharmaceuticals Corporation | $115.28 | 2019-2024 | |
| Boston Scientific Corporation | $111.61 | 2022 | |
| Melinta Therapeutics, LLC | $63.16 | 2021-2022 | |
| Genzyme Corporation | $39.10 | 2020 | |
| Mallinckrodt Hospital Products INC. | $34.35 | 2022 | |
| Impulse Dynamics (USA) INC. | $32.55 | 2022 | |
| Distalmotion US | $27.32 | 2025 | Dexter L6 Robot |
| Bayer Healthcare Pharmaceuticals INC. | $22.29 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $20.46 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.74 | 2023 | Jardiance |
| Merck Sharp & Dohme LLC | $15.02 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.56 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.